loadpatents
Patent applications and USPTO patent grants for SEBHAT; Iyassu.The latest application filed is for "gpr40 agonists".
Patent | Date |
---|---|
Gpr40 Agonists App 20220289772 - SEBHAT; Iyassu ;   et al. | 2022-09-15 |
AMPK activators Grant 11,407,768 - Sebhat , et al. August 9, 2 | 2022-08-09 |
Ampk Activators App 20220227754 - SEBHAT; Iyassu ;   et al. | 2022-07-21 |
Gpr40 Agonists App 20220226298 - SEBHAT; Iyassu ;   et al. | 2022-07-21 |
Gpr119 Agonists App 20220153719 - SEBHAT; Iyassu ;   et al. | 2022-05-19 |
Gpcr Combination Therapies App 20220152164 - THORNBERRY; Nancy ;   et al. | 2022-05-19 |
Ampk Activators App 20220033401 - SEBHAT; Iyassu ;   et al. | 2022-02-03 |
Ampk Activators App 20220002317 - SEBHAT; Iyassu ;   et al. | 2022-01-06 |
Azabenzimidazole tetrahydrofuran derivatives Grant 9,868,733 - Apgar , et al. January 16, 2 | 2018-01-16 |
Indole derivatives useful as anti-diabetic agents Grant 9,650,375 - Acton, III , et al. May 16, 2 | 2017-05-16 |
Benzimidazole hexahydrofuro[3,2-b]furan derivatives Grant 9,556,193 - Apgar , et al. January 31, 2 | 2017-01-31 |
Benzimidazole tetrahydrofuran derivatives Grant 9,540,364 - Apgar , et al. January 10, 2 | 2017-01-10 |
Benzimidazole tetrahydropyran derivatives Grant 9,527,839 - Apgar , et al. December 27, 2 | 2016-12-27 |
Azabenzimidazole tetrahydropyran derivatives Grant 9,382,243 - Apgar , et al. July 5, 2 | 2016-07-05 |
Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives Grant 9,290,517 - Apgar , et al. March 22, 2 | 2016-03-22 |
Novel Indole Derivatives Useful As Anti-diabetic Agents App 20160002224 - Acton, III; John J. ;   et al. | 2016-01-07 |
Novel Azabenzimidazole Hexahydrofuro[e,2-b]furan Derivatives App 20150284411 - Apgar; James M. ;   et al. | 2015-10-08 |
Novel Benzimidazole Tetrahydrofuran Derivatives App 20150218149 - Apgar; James M. ;   et al. | 2015-08-06 |
Novel Benzimidazole Hexahydrofuro[3,2-b]furan Derivatives App 20150218183 - Apgar; James M. ;   et al. | 2015-08-06 |
Novel Azabenzimidazole Tetrahydropyran Derivatives App 20150210685 - Apgar; James M. ;   et al. | 2015-07-30 |
Novel Azabenzimidazole Tetrahydrofuran Derivatives App 20150203487 - Apgar; James M. ;   et al. | 2015-07-23 |
Novel Benzimidazole Tetrahydropyran Derivatives App 20150197516 - Apgar; James M. ;   et al. | 2015-07-16 |
Cyclic azabenzimidazole derivatives useful as anti-diabetic agents Grant 8,796,258 - Anand , et al. August 5, 2 | 2014-08-05 |
Cyclic benzimidazole derivatives useful as anti-diabetic agents Grant 8,563,746 - Dang , et al. October 22, 2 | 2013-10-22 |
Novel Cyclic Azabenzimidazole Derivatives Useful As Anti-diabetic Agents App 20130123237 - Anand; Rajan ;   et al. | 2013-05-16 |
Cyclic benzimidazole derivatives useful as anti-diabetic agents Grant 8,410,284 - Dang , et al. April 2, 2 | 2013-04-02 |
Cyclic benzimidazole derivatives useful as anti-diabetic agents Grant 8,394,969 - Bookser , et al. March 12, 2 | 2013-03-12 |
Cyclic benzimidazole derivatives useful as anti-diabetic agents Grant 8,329,914 - Bao , et al. December 11, 2 | 2012-12-11 |
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents App 20110263533 - Dang; Qun ;   et al. | 2011-10-27 |
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents App 20110218174 - Bao; Jianming ;   et al. | 2011-09-08 |
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents App 20110195964 - Dang; Qun ;   et al. | 2011-08-11 |
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents App 20100081643 - BOOKSER; BRETT C. ;   et al. | 2010-04-01 |
Substituted piperidines as melanocortin-4 receptor agonists App 20020137664 - Bakshi, Raman K. ;   et al. | 2002-09-26 |
Substituted piperidines as melanocortin-4 receptor agonists Grant 6,350,760 - Bakshi , et al. February 26, 2 | 2002-02-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.